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Cholesterol is an essential constituent of cell membranes and the regulation of cholesterol concentration is critical for cell functions including
signaling. In this paper, we applied resonant waveguide grating (RWG) biosensor to study the cellular functions of cholesterol through real time
monitoring the dynamic mass redistribution (DMR) mediated by cholesterol depletion with methyl-β-cyclodextrin (mβCD). In A431 cells,
depletion of cholesterol by mβCD led to a DMR signature that was similar, but not identical to that induced by epidermal growth factor (EGF). To
elucidate the cellular mechanisms of the DMR signal mediated by cholesterol depletion, a panel of modulators that specifically modulate the
activities of various cellular targets were used to pretreat the cells. Results showed that the DMR signals triggered by cholesterol depletion are
primarily linked to the transactivation of EGF receptor. Multiple signaling pathways including Ras/mitogenic activated protein (MAP) kinase,
protein kinase C (PKC) and phosphatidylinositol 3-kinase (PI3K) acted synergically in the cell response, whereas the activation of protein kinase
A (PKA) pathway was found to antagonize the cell response.
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Cholesterol in most mammalian cell membranes tends to
assemble membrane microdomains, such as lipid rafts and
caveolae, with other lipids including sphingolipids and
saturated phospholipids [1–4]. Lipid rafts function to selective-
ly compartmentalize numerous signaling proteins. These
dynamic cholesterol-enriched microdomains play critical roles
in numerous cellular processes including protein sorting, signal
transduction, and membrane trafficking [5–10]. For these
functions, cholesterol levels in cells are tightly and preciselyAbbreviations: EGF, epidermal growth factor; EGFR, EGF receptor; ERK,
extracellular signal-related kinase; OSBP, oxysterol-binding protein; MAPK,
mitogen-activated protein kinase; mβCD, methyl-β-cyclodextrin; RWG,
resonant waveguide grating; DMR, dynamic mass redistribution; DMEM,
Dulbecco's modified Eagle's medium; FBS, fetal bovine serum; PKC, protein
kinase C; PKA, protein kinase A; PI3K, phosphatidylinositol 3-kinase; HBSS,
1× regular Hank's balanced salt solution, 20 mM Hepes buffer, pH 7.0, 2.5 mM
probenecid
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of lipoprotein cholesterol into cells, and efflux from the cells.
Disruption of these microdomains by cholesterol extraction
has profound effects on cell functions. Cholesterol depletion not
only increases the mechanic flexibility of cell membranes, thus
increasing passive permeability [1], but also causes the
disappearance of invaginations of cell surface membranes
[11]. Cholesterol depletion results in the delocalization of many
signaling molecules including epidermal growth factor (EGF)
receptor [12–15] and lipids such as cellular phosphatidylino-
sitol biphosphate [16,17], and also triggers membrane traffick-
ing [18,19]. Interestingly, cholesterol extraction alone leads to
the activation of several cellular signaling pathways including
extracellular signal-related kinase (ERK) [20]. Recently, Wang
et al. [21] have provided a link between cholesterol depletion
and ERK activation in engineered HeLa cells. Oxysterol-
binding protein (OSBP) functions as a cholesterol-binding
scaffolding protein coordinating the activity of two phospha-
tases (PP2A and HePTP) to control the ERK signaling pathway.
Depletion of cholesterol disassembles the complex and releases
the phosphatases from OSBP, resulting in the activation of
ERK. However, the downstream target(s) of phosphatases are
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One of the likely targets in certain cell lines is EGF receptor
(EGFR). The EGFRs converge multitude signals including EGF
[22,23] and mitogenic G protein-coupled receptor agonists [24–
26] into Ras/mitogenic-activated protein kinase (MAPK)
pathway that leads to cell proliferation. Although EGFR is
partly localized to lipid rafts but not enriched in caveolae in both
A431 and Hep-2 cells [11], cholesterol depletion by methyl-β-
cyclodextrin (mβCD) not only transactivates the EGFR in a
ligand-independent manner in both A431 and Cos-1 cells
[12,13], but also increases EGF-induced receptor phosphoryla-
tion [20,27].
To date, rich information has been available about the
cellular distribution, trafficking and functions of cholesterol.
However, since these cholesterol-enriched microdomains are
tiny (∼tens of nanometers) and dynamic, indirect measurements
that are generally used to study the cholesterol functions often
lead to controversial results. Recently, we had developed an
approach of ligand-induced dynamic mass redistribution
(DMR) in living cells using resonant waveguide grating
(RWG) biosensor [28] and applied it to map the signaling
network of the EGFR in A431 cells [29], as well as of
bradykinin B2 receptor signaling in A431 [30]. A ubiquitous
optical signature relating to the dynamic mass redistribution due
to EGFR activation had been identified and linked primarily to
the activation of the Ras/MAPK pathway [29]. Similar to other
optical biosensors including surface plasmon resonance [31],
the RWG biosensor is a label free technology capable of
detecting refractive index changes—proportional to local mass
redistribution in living cells near the sensor surface [32]. In this
paper, we applied the RWG biosensor to study the cellular
functions of cholesterol through monitoring in real time the
DMR mediated by cholesterol extraction with mβCD.
2. Materials and methods
2.1. Regents
Methyl-β-cyclodextrin, probenecid, ethylene glycol-bis(2-aminoethylether)-
N,N,N,N-tetraacetic acid (EGTA), and EGF were purchased from Sigma
Chemical Co. (St. Louis, MO). AG1478, 8-bromo-cAMP, forskolin,
GF109203x, KN-62, KT 5720, KT5823, NKH477, PP1, SB203580,
SP600125, staurosporine, U0126, and wortmannin were obtained from Tocris
Chemical Co. (St. Louis, MO). Fluo-3, and Texas Red-labeled phalloidin were
obtained from Molecular Probes (Eugene, OR). Both total MEK1 and phosph-
MEK1 (Ser217/221) sandwich ELISA kits were purchased from Cell Signaling
Technology (Beverly, MA). Poly-colonal anti-vinculin (Sigma) was labeled with
monoamine reactive-Cy3 (GE Healthcare, Piscataway, NJ), following the
standard protocol recommended by the supplier. Corning® Epic™ 96 well
biosensor microplates were obtained from Corning Inc (Corning, NY), and
cleaned by exposure to high intensity UV light (UVO-cleaner, Jelight Company
Inc., Laguna Hills, CA) for 6 min before use.
2.2. Cell culture
Human epidermoid carcinoma A431 cells (American Type Cell Culture)
were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented
with 10% fetal bovine serum (FBS), 4.5g/l glucose, 2 mM glutamine, and
antibiotics. ∼3–7.5×104 cells suspended in 200 μl the DMEM medium
containing 10% FBS were placed in each well of a 96 well biosensor microplate,
and were cultured at 37 °C under air/5% CO2 until ∼95% confluency wasreached (∼2–4 days). The cells were then subject to starvation using the medium
with or without 0.1% FBS for about 20 h. To make sure the quality and density
of cells on the surfaces of sensor microplates, the resulted quiescent cells were
examined with light microscopy before assays.
2.3. Optical biosensor measurements
Corning® Epic™ angular interrogation system with transverse magnetic or
p-polarized TM0 mode was used for all studies. The details of both instrument
and assay protocol were previously described [28]. Briefly, after starvation, the
cells were washed twice and maintained with 100 μl the corresponding
starvation medium. Afterwards, the sensor microplate containing cells was
placed into the optical system, and the cell responses were recorded before and
after addition of a solution. For compound studies, the cells in each well were
pretreated with a compound solution of 50 μl or the HBSS buffer solution until a
steady phase (i.e., no obvious mass redistribution) was reached (generally within
1 h), before mβCD solution of 50 μl was introduced. Since the baseline of the
responses varied from well to well, we normalized the mβCD-induced response
in the absence and presence of a compound at the time when the cells are in
steady state before the mβCD treatment. All studies were carried out at room
temperature with the lid of the microplate on except for a short period of time
(∼seconds) when the solution was introduced, in order to minimize the effect of
temperature fluctuation and evaporative cooling.
2.4. Intracellular Ca2+ measurements
A431 at passage 3 to 5 were grown in either the biosensor microplate or
Costar™ 96 well clear cell culture microplates until ∼95% confluency, washed
twice and starved overnight with the DMEM only, washed with assay buffer
containing 1× HBSS buffer (20 mM HEPES pH 7.0, HBSS, and 2.5 mM
probenecid), and labeled in the same buffer containing 4 μMFluo-3 for 1 h at 37
°C and 5% CO2. The cells were then washed twice with buffer, and treated with
a compound individually for 1 h at room temperature. The assay was initiated by
transferring an equal volume of mβCD solution to the cell plate, and calcium
signal was recorded over 6 min with a 6-s interval using a PerkinElmer
microplate reader. Four replicate examples were examined.
2.5. Measurements of phosphorylated MEK1 with ELISA assays
The total and phosphorylated MEK1 were quantified using the total and
phosph-MEK1 sandwich ELISA kits from Cell Signaling Technology. Briefly,
cells were grown in Costar™ 96 well clear cell culture microplates until ∼95%
confluency, washed twice with the DMEM medium, and starved in the medium
for overnight. After treated with 5 mM mβCD at room temperature for certain
time, the cells were lysed with sonication in an ice-water bath. After being
centrifuged at 4 °C, supernatant of 4 replicate wells were collected and combined
for sequential analysis. The ELISA assays were carried out using the protocols
recommended by the supplier, except that an extra step for blocking the non-specific
binding with 1% bovine serum albumin was added, before the sample loading.
2.6. Fluorescence imaging
Cells were grown on glass coverslips, starved for overnight with serum-free
DMEM medium, chased with either 16 nM EGF or 5 mM mβCD for certain
time, fixed with 4% paraformaldehyde, permeabilized in phosphate-buffered
saline (PBS) containing 0.2% Triton, and blocked with 1% bovine serum
albumin (BSA). Afterwards, cells were incubated with 0.5 μM Texas Red-
labeled phalloidin, or Cy3-labeled anti-vinculin for 1 h at room temperature, and
washed. After final washes and mounting, cells were examined with a 40×
objective. A Zeiss Axioplan fluorescence microscope was used to collect all
fluorescence and light images.
3. Results
The mβCD is a widely used acceptor to rapidly extract the
cell membrane cholesterol through a process known as
Fig. 1. The optical signature, relating to the dynamic mass redistribution, of
quiescent A431 cells in response to the mβCD treatment, as plotted by the shifts
in the central position of the resonant band of a sensor as a function of time
before and after stimulation. Quiescent A431 cells were obtained by culturing
with DMEM medium containing 0.1% fetal bovine serum (FBS) (A) and
without any FBS for 20 h (B). The responses induced by 4 nM EGF, or the
vehicle HBSS buffer alone were presented for comparison. The arrows indicated
the time when the solution was introduced.
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Since we previously used A431 cells – a cell line endogenously
over-expressed EGFRs [33] for mapping EGFR signaling
network with the RWG biosensor [29], this cell line was used
for studying the cellular functions of cholesterol. In A431,
cholesterol extraction by mβCD triggers several well-charac-
terized cell responses, including the disappearance of invagina-
tions [11], delocalization of phosphatidylinositol bisphosphate
[16,17], and ligand-independent EGFR transactivation [12,13].
We hypothesized that some of these events could lead to ordered
and dynamic redistribution of intracellular targets, molecular
assemblies and even the whole cells (e.g., cell morphological
changes), thus resulting in a dynamic mass redistribution. When
such mass redistribution occurs within the sensing volume of
the biosensors [28–30], it causes the changes of reflected light
from the sensor, thus generating a unique optical signature. It is
possible that the activation of distinct cell signaling mediated
through different targets might result in similar overall DMR
signal. However, similar to the common approaches used for
conventional cell signaling studies, the modulation profiles
induced by an array of selective modulators might provide a
means to classify the specificity of cell signaling being activated
by a particular stimulus, because of the participation of unique
sets of cellular targets for a specific signaling event. Thus,
similar to the optical signatures mediated by EGF stimulation,
the mβCD-induced optical signature should be also useful to
study the cellular functions of cholesterol in A431 cells.
Since higher doses (N8 mM) of mβCD cause some
populations of cells detaching from the sensor surface and
death (data not shown), we were primarily focused on the effect
of mβCD at a concentration below 8 mM. The quiescent A431
cells were obtained using two different starvation conditions:
0.1% FBS and 0% FBS (both were 20 h). Fig. 1A showed the
optical signature, correlating to the dynamic mass redistribu-
tion, of quiescent A431 cells mediated by mβCD at 1, 5 and
8 mM. Results showed that mβCD triggered a dose-dependent
DMR response, with an overall dynamics that is similar to that
induced by 4 nM EGF. Before cholesterol extraction, the cells
exhibited a flat response, meaning that the cells are in a steady
state and no obvious redistribution in mass occurs in the cells.
After mβCD was introduced, there was a rapid signal lasting
less than 20 s, primarily due to a bulk index change. After that,
the cells responded with a DMR signal consisting of three
distinct, sequential phases: (i) a positive phase with increased
signal (P-DMR), (ii) a transition phase, and (iii) a decay phase
(N-DMR). The change in mass is an indicator for the
movements of target proteins or assemblies towards or away
from the sensor surface in response to treatment. Similar to the
EGF-induced response, switching the starvation medium from
DMEM containing 0.1% FBS to DMEM only also accelerated
the kinetics of the response, while the vehicle (i.e., HBSS
buffer) used did not result in any significant responses (Fig. 1B).
These behaviors suggested that both mβCD and EGF treatment
leads to a similar cell response.
One possible mechanism is that in A431 cells depletion of
cholesterol from the plasma membrane by mβCD transactivates
the EGFR, probably via the auto-activation of Src [8]. To testthat, we pretreated the quiescent cells with AG1478 (an EGFR
tyrosine kinase inhibitor), or PP1 (a specific Src inhibitor).
Results showed that AG1478 at 10 μM fully suppressed the
response, whereas PP1 only partially attenuated the response
(43±5% suppression, n=3, based on the amplitude of the N-
DMR event; similar numbers are indicated in the rest of paper)
(Fig. 2). These results indicated the dominant role of EGFR
tyrosine kinase activity in the cell response triggered by
cholesterol depletion, while Src also involved in the response,
probably through phosphorylating the tyrosine 845 on the
receptor [13,34].
However, there are some noticeable differences between the
EGF- and mβCD- induced cell responses of quiescent A431
cells. In general, compared to EGF, mβCD triggered a P-DMR
phase with greater amplitude. Besides the recruitment of
Fig. 3. The increase in intracellular Ca2+ level of quiescent A431 cells induced
by 5 mM mβCD. The cells were pre-treated (about 30 min) with HBSS
(control), 10 μM AG1478, or 3 mM EGTA.
Fig. 2. The effect of an EGFR tyrosine kinase inhibitor AG1478 (1, 10 μM), and
a Src kinase inhibitor PP1 (10 μM) on the 5 mM mβCD-induced response of
quiescent A431 cells. The cells pretreated with HBSS at the same volume as the
compound solution (50 μl) were used as a positive control.
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the P-DMR phase, the flatness of cells induced by cholesterol
extraction [35] may also contribute to the greater amplitude of
the P-DMR phase observed. Another possibility is influx of Ca2+
and its associated mass movement caused by cholesterol
depletion, as demonstrated by intracellular Ca2+ measurements.
Treatment of cells with mβCD triggered an immediately
elevated and prolonged intracellular Ca2+ level, which it
increased by 45±15%, as measured 25 s after the mβCD
treatment. Such elevated Ca2+ level could be fully blocked by
EGTA (3 mM), but not AG1478 or PP1 both at 10 μM (Fig. 3).
This rapid kinetics (within seconds) is consistent with the
effluxing kinetics of the rapid pool of cell surface membrane
cholesterol [19].
Unlike the significant difference between the EGF- and
mβCD-induced P-DMR signals, the treatment of quiescent
A431 cells with either mβCD or EGF resulted in a similar N-
DMR event, but with different amplitudes. In quiescent A431
cells using 0.1% FBS, the amplitude of the N-DMR event
induced by 5 mM or 8 mM mβCD was 0.76±0.12 (n=4), and
0.92±0.15 (n=2) unit, respectively. Both net changes were
smaller than that induced by 4 nM EGF (1.75±0.26 unit, n=3).
However, in quiescent A431 cells using DMEM without any
FBS, treatment with either 5 mM mβCD or 4 nM EGF resulted
in almost identical net changes (∼1.75) in the amplitude of the
N-DMR event, while 32 nM EGF results in a net change of
∼2.5 [29]. Our previous studies showed that the N-DMR event
of quiescent A431 cells mediated by EGF mainly proceeds
through MEK, and correlates to the cell detachment from the
substrate after EGFR activation [29]. The similarity between
mβCD- and EGF-mediated N-DMR events suggested that
mβCD might also trigger similar changes in cell morphology
and cell adhesion statues. To test that, we compared the staining
patterns of mβCD-treated cells with EGF-treated cells. As
shown in the fluorescence images after being stained with Texas
Red-labeled phalloidin, cholesterol depletion by mβCD led tosignificant actin remodeling of quiescent cells, as indicated by
the rim of filamentous actin at the edge of the cells (Fig. 4A).
The mβCD-triggered actin remodeling showed similar kinetics
and patterns to those mediated by 16 nM EGF (Fig. 4A; data not
shown). Furthermore, cholesterol depletion by mβCD resulted
in clear changes in cell adhesion which also are similar to those
mediated by 16 nM EGF, as showed in the staining pattern of
vinculin (Fig. 4B). Such similarities suggested that cholesterol
depletion by mβCD might trigger EGFR transactivation, and
ultimately lead to actin remodeling and cell detachment.
One possibility for the smaller amplitude of the N-DMR
phase induced by mβCD is that cholesterol depletion alone
couldn't cause maximum phosphorylation of the receptor. To
test that, we further stimulated the cells with 16 nM EGF after
5 mM mβCD treatment. Compared to the response induced by
EGF without any pretreatment, the sequential EGF stimulation
led to a response with almost identical dynamics but much
smaller amplitude (Fig. 5A). Conversely, the pretreatment of
A431 with 16 nM EGF totally blocked the mβCD-induced
response (Fig. 5B). Furthermore, the co-stimulation of the cells
with a solution containing EGF (4 or 8 nM) and 5 mM mβCD
led to a N-DMR event that its amplitude (2.1±0.23, n=3) was
only slightly smaller than that induced by 32 nM EGF alone, but
the mixture led to a P-DMR with a greater amplitude (data not
shown). Taken together, these results suggested that in A431
cholesterol depletion transactivates the EGFR, but cholesterol
depletion alone cannot fully activate the EGFR.
One hypothesis is that the difference in the optical signature
between mβCD and EGF may be contributed to the distinct
activation of signaling pathways and network interactions
mediated by two stimuli. Alternatively, mβCD may trigger
other unknown signaling events. To test those, modulators that
specifically regulate distinct intracellular targets were used to
pretreat the cells. The concentrations of the modulators used
were chosen based on their EC50 reported in literature such that
maximum inhibitions or activations of their specific targets are
achieved with minimal crosstalk to other targets. The effect of
those various modulators on the mβCD-induced response, an
Fig. 5. The time-dependent response of quiescent A431 cells (obtained with
DMEM medium without FBS, 20 h) sequentially stimulated with (A) 5 mM
mβCD, and 4 nM EGF, respectively; (B) 16 nM EGF and 5 mM mβCD,
respectively.
Fig. 4. mβCD and EGF induced similar changes in cell morphology and adhesion statues at room temperature. A431 cells treated with either 16 nM EGF or 5 mM
mβCD for 30 min were stained for actin with Texas Red-labeled phalloidin (A) or for focal adhesion with Cy3-labeled antivinculin antibody (B). The bar represents
20 μm.
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the cellular functions of cholesterol, can be analyzed by
normalizing the mβCD-induced response at the time when the
cells reach a steady state after being treated with modulators, but
before the mβCD treatment.
Since mβCD transactivates the EGFR in Cos-1 cells [12] that
induces MAPK activation and the EGF-induced optical
signature in A431 is primarily due to the activation of the
Ras/MAPK pathway [29], we first examined the effect of
modulators targeting the Ras/MAPK pathway. The data shown
in Fig. 6A indicated that U0126 (a potent MEK1/2 inhibitor)
only partially attenuated the N-DMR signal (47±5.2%, n=3),
whereas neither SB203580 (a selective p38 MAPK inhibitor)
nor SP600125 (a JNK inhibitor) had any obvious effect on the
response. The activation of MAPK pathway was also
confirmed by determining the phosphorylated MEK1 in
A431 using ELISA assays (Fig. 6B). Cholesterol depletion
triggered a dynamic and elevated phosphorylation of MEK1,
which reaches ∼60% of the total of MEK1 at around 10 min
and starts to decay over time after the cells were treated with
mβCD. Those results suggested that the Ras/MAPK pathway
is activated, and involved in, but not solely determining the
overall cell response.
In A431 cells, cholesterol depletion by mβCD triggers the
phosphorylation of EGFR tyrosine residues 1173 and 992-two
phosphotyrosine sites of the activated EGFR to which
phospholipase Cγ (PLCγ) specifically binds [12,13], suggest-
ing the potential involvement of both phospholipase Cγ and
PI3K pathways. Thus, we examined the effect of inhibitors that
target both signaling pathways. Pre-treatment of quiescent
A431 with wortmannin (a PI3K inhibitor) led to a 62±7.3%
(n=2) reduction of the response (Fig. 7), suggesting the positive
contribution of PI3K activation in the cell response. Interest-
ingly, protein kinase C inhibitor GF109203x partially sup-
pressed the N-DMR signal (53.4±5.8%, n=2), whereas a
Fig. 7. The effect of protein kinase inhibitors on the mβCD-induced response of
quiescent A431 cells. The inhibitors were GF109203x (1 μM), wortmannin
(1 μM), KT5720 (1 μM), KT5823 (1 μM), staurosporine (1 μM), and KN62
(10 μM).
Fig. 6. (A) The effect of MAPK pathway modulators on the mβCD-induced
response of quiescent A431 cells. The modulators were U0126 (1 μM),
SB203580 (10 μM), and SP600125 (1 μM). (B) Quantification of both the total
and phosph-MEK1 levels in quiescent A431 cells without any treatment
(control) and treated with 5 mM mβCD (10 and 30 min). The OD450 readings
were obtained due to the cleavage of TMB substrate.
Fig. 8. The effect of protein kinase A pathway modulators on the mβCD-
induced response of quiescent A431 cells. The modulators were KT5720
(1 μM), 8-bromo-cAMP (50 μM), NKH447 (10 μM), and forskolin (10 μM).
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delayed the transition time from the P-DMR to N-DMR phase
with a smaller suppression of the N-DMR event (23.9±6.3%,
n=2). Conversely, KT5823 (an inhibitor of protein kinase G), or
KN 62 (an inhibitor of CaM kinase II) had little effect on the
response. These date suggested that both PI3K and PKC, but
not PKG or CaM kinase II, involve the overall cell response;
and signaling downstream PKC but upstream CaM Kinase II
plays an important role in the cell response.
The activation of protein kinase A (PKA) by the elevating
level of cAMP has been shown to antagonize the activation of
the Ras/MAPK pathway mediated through the EGFR [36,37].
We further examined the effect of modulators that target the
PKA pathway. KT 5720 (an inhibitor of protein kinase A) had
little effect on the mβCD-induced response (Fig. 7). In striking
contrast, either a PKA activator 8-bromo-cAMP, or twoadenylyl cyclase activators NKH447 or forskolin resulted in
significant suppression (all near 70%) of the N-DMR signal
(Fig. 8). The activation of adenylyl cyclase by forskolin and its
water-soluble analog NKH447 led to the cAMP generation that
activates the PKA, which, in turn, antagonizes the MAPK
pathways, possibly through deactivation of Raf-1 [37]. Thus,
these results implied again that in A431 cholesterol depletion
activates the MAPK pathway.
4. Discussion
Cholesterol is enriched in certain plasma membrane domains
such as caveolae and lipid rafts. The spatial segregation of
cholesterol in the plasma membrane has been implicated to play
important roles in signal transduction, as evidenced by the effect
of removal of cholesterol from the plasma membrane on a
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this study, we provided insights in the cellular functions of
cholesterol by its removal in A431 cells, as being examined with
RWG biosensor. The biosensors offered an optical signature,
relating to the dynamic mass redistribution, of the mβCD-
mediated cell responses. Based on the previous study on the
EGF-induced cell signaling [29], we mainly used the character-
istics of the N-DMR event as a quantitative means to map the
signaling pathways triggered by the removal of cholesterol.
In A431 cells, cholesterol depletion by mβCD increases in
both basal and EGF-stimulated EGF receptor phosphorylation.
The phosphorylation pattern of EGFR mediated by cholesterol
depletion [12,13] was significantly different from that induced
by EGF [34]. The elevated levels of the phosphorylation of
Tyr845, Tyr992, and Tyr1173, and to less extent of Tyr1068
induced by cholesterol depletion were associated with an
increase in the intrinsic kinase activity of the EGF receptor
kinase [13]. In the same cell line, we had identified an EGF-
induced optical signature that primarily involves the Ras/
MAPK signaling [29]. Three lines of evidence suggested that
cholesterol removal by mβCD transactivates the EGFR, thus
leading to ERK activation. First, the mβCD treatment led to an
optical signature of quiescent A431 cells that was similar to that
mediated by EGF. Secondly, an EGFR tyrosine kinase inhibitor
AG1478 almost totally blocked the cell response, suggesting the
dominant role of EGFR activation in the cell response.
However, an Src kinase inhibitor PP1 only partially attenuated
the cell response. Since the Tyr845 is a site in the kinase
activation loop of the receptor that is known to be phosphor-
ylated by pp60src [38], the partial attenuation of the response by
PP1 indicated that the increase in EGFR kinase activity might
not be solely as a result of the phosphorylation of Tyr845 by
pp60src induced by the mβCD treatment. Thirdly, the
pretreatment of cells with EGF also totally blocked the
mβCD-induced cell response, suggesting that both stimuli
mediate cell response through the EGFR.
The smaller amplitude of the N-DMR event induced by
mβCD suggested that the mβCD treatment alone couldn't lead
to the maximum phosphorylation of the EGF receptor, as does
by EGF at appropriate concentrations [22,23,29]. This was
further supported by the cell responses of a sequential
stimulation with 4 nM EGF, and of the co-stimulation by both
EGF and mβCD. Lack in endocytosis of the activated receptors
by the mβCD treatment [39] may be another resource that
contributes to the difference observed between the mβCD- and
EGF-induced responses.
The site-specific tyrosine phosphorylation of the EGF
receptor by the mβCD treatment suggested that cholesterol
depletion could preferentially activate specific pathways [13].
The similarity between the mβCD- and EGF-induced optical
signatures of quiescent A431 cells suggested that cholesterol
removal may also lead to the ERK activation that ultimately
causes cell detachment from the substrate [40,41], possibly
through the Ras/MAPK pathway due to the EGFR transactiva-
tion. Three lines of evidence supported the involvement of this
pathway in cell response. First, cholesterol depletion led to an
elevated and dynamic phosphorylation of MEK1, as measuredwith ELISA assays. Secondly, a potent and selective MEK
inhibitor U0126 at least partially attenuates the βCD-induced
DMR events. Thirdly, the activation of protein kinase A directly
by 8-bromo-cAMP or indirectly through the cAMP generation
by forskolin and NKH447 also led to the partial attenuation of
the mβCD-induced response. The antagonized activity of the
PKA activation might be through the deactivation of Raf-1
[36,37], and provided additional evidence that the activation of
the Ras/MAPK pathway through the activated EGFR was
involved in the cell response induced by mβCD.
However, the inability of U0126 to fully block the cell response
indicated that there is at least another signaling pathway involved in
the cell response. The partial attenuation of the response by either
PI3K or PKC inhibitors suggested the involvement of both PI3K
and PKC pathways in the overall cell response, as implied by the
selectively enhanced phosphorylatio0n of Tyr1173 and 992—two
phosphotyrosine sites to which PLCγ specifically binds [13]. This
was consistent with recent observationsmade inHepG2 cellswhich
specific isoform PKCs involve in the Raf/MEK/p42/p44MAPK
cascade [42]. In addition, co-pretreatment of A431 with wortman-
nin, GF109203x and U0126 fully blocked the cell responses (data
not shown), suggesting that these three pathways work together to
determine the specific cell response.
The data presented here clearly demonstrated that the mβCD
treatment resulted in the activation of the endogenous EGFR,
and leaded to signaling events through at least the Ras/MAPK,
PI3K and PKC pathways. These signaling pathways acted
synergetically, whereas the PKA activation at least partially
antagonized the mβCD-induced response. The unique optical
signatures, obtained using optical biosensors, of A431 cells
mediated by cholesterol removal provided a useful and
alternative means to study the cellular functions of cholesterol
in living cells. Our findings provided insights in the important
roles of cholesterol in cell function, particularly the EGFR
transactivation.References
[1] K. Simons, E. Ikonen, How cells handle cholesterol, Science 290 (2000)
1721–1726.
[2] F. Schroeder, A.M. Gallegos, B.P. Atshaves, S.M. Storey, A.L. McIntosh,
A.D. Petrescu, H. Huang, O. Starodub, H. Chao, H. Yang, A. Frolov, A.B.
Kier, Recent advances in membrane microdomains: rafts, caveolae, and
intracellular cholesterol trafficking, Exp. Biol. Med. 226 (2001) 873–890.
[3] F. Galbiati, B. Razani, M.P. Lisanti, Emerging themes in lipid rafts and
caveolae, Cell 106 (2001) 403–411.
[4] L.D. Zajchowski, S.M. Robbins, Lipid rafts and little caves: compartmen-
talized signalling in membrane microdomains, Eur. J. Biochem. 269 (2002)
737–752.
[5] E.J. Smart, G.A. Graf, M.A. McNiven, W.C. Sessa, J.A. Angelman, P.E.
Scherer, T. Okamoto, M.P. Lisanti, Caveolins, liquid-ordered domains, and
signal transduction, Mol. Cell. Biol. 19 (1999) 7289–7304.
[6] K. Simons, D. Toomre, Lipid rafts and signal transduction, Nat. Rev., Mol.
Cell Biol. 1 (2000) 31–41.
[7] J.P. Incardona, S. Eaton, Cholesterol in signal transduction, Curr. Opin.
Cell Biol. 12 (2000) 193–203.
[8] S. Li, J. Couet, M.P. Lisanti, Src tyrosine kinases, G alpha subunits and
H-Ras share a common membrane-anchored scaffolding protein,
caveolin. Caveolin binding negatively regulates the auto-activation of
Src tyrosine kinases, J. Biol. Chem. 271 (1996) 29182–29190.
261Y. Fang et al. / Biochimica et Biophysica Acta 1763 (2006) 254–261[9] K.S. Song, S. Li, T. Okamoto, L. Quilliam, M. Sargiacomo, M.P. Lisanti,
Copurification and direct interaction of Ras with caveolin, an integral
membrane protein of caveolae microdomains. Detergent free purification
of caveolae membranes, J. Biol. Chem. 271 (1996) 9690–9697.
[10] S.K. Rodal, G. Skretting, O. Garred, F. Vilhardt, B. van Deurs, K.
Sandvig, Extraction of cholesterol with methyl-β-cyclodextrin perturs
formation of clathrin-coated endocytic vesicles, Mol. Biol. Cell 10 (1999)
961–974.
[11] T. Ringerike, F.D. Blystad, F.O. Levy, I.H. Madshus, E. Stang, Cholesterol
is important in control of EGF receptor kinase activity but EGF receptors
are not concentrated in caveolae, J. Cell Sci. 115 (2002) 1331–1340.
[12] X. Chen, M.D. Resh, Cholesterol depletion from the plasma membrane
triggers ligand-independent activation of the epidermal growth factor
receptor, J. Biol. Chem. 277 (2002) 49631–49637.
[13] E.J. Westover, D.F. Covey, H.L. Brockman, R.E. Brown, L.J. Pike,
Cholesterol depletion results in site-specific increases in epidermal growth
factor receptor phosphorylation due to membrane level effects: studies
with cholesterol enantiomers, J. Biol. Chem. 278 (2003) 51125–51133.
[14] P. Liu, Y. Ying, Y.G. Ko, R.G.W. Anderson, Localization of platelet-
derived growth factor-stimulated phosphorylation cascade to caveolae,
J. Biol. Chem. 271 (1996) 10299–10303.
[15] P.-Y. Wang, P. Liu, J. Weng, E. Sontag, R.G.W. Anderson, A cholesterol-
regulated PP2A/HePTP complex with dual specificity ERK1/2 phospha-
tase activity, EMBO J. 22 (2003) 2658–2667.
[16] L.J. Pike, L. Gasey, Localization and turnover of phosphatidylinositol 4,5-
bisphosphate in caveolin-enriched membrane domains, J. Biol. Chem. 271
(1996) 26453–26456.
[17] L.J. Pike, J.M. Miller, Cholesterol depletion delocalizes phosphatidylino-
sitol bisphosphate and inhibits hormone-stimulated phosphatidylinositol
turnover, J. Biol. Chem. 273 (1998) 22298–22304.
[18] E.M. Lindholm, A.M. Palmer, A. Graham, Triacylglycerol-rich lipopro-
teins alter the secretion, and the cholesterol effluxing function, of
apolipoprotein E-containing lipoprotein particles from human (THP-1)
macrophages, Biochem. J. 356 (2001) 515–523.
[19] M.P. Haynes, M.C. Phillips, G.H. Rothblat, Efflux of cholesterol from
different cellular pools, Biochemistry 39 (2000) 4508–4517.
[20] T. Furuchi, R.G.W. Anderson, Cholesterol depletion of caveolae causes
hyperactivation of extracellular signal-related kinase (ERK), J. Biol.
Chem. 273 (1998) 21099–21104.
[21] P.Y. Wang, J. Weng, R.G.W. Anderson, OSBP is a cholesterol-regulated
scaffolding protein in control of ERK1/2 activation, Science 307 (2005)
1472–1476.
[22] J. Schlessinger, Cell signaling by receptor tyrosine kinases, Cell 103
(2000) 211–225.
[23] B. Schoeberl, C. Eichler-Jonsson, E.D. Gilles, G. Muller, Computational
modeling of the dynamics of the MAP kinase cascade activated by surface
and internalized EGF receptors, Nat. Biotechnol. 20 (2002) 370–375.
[24] H. Daub, F. Uz, C. Weiss, A. Wallasch, Role of transactivation of the EGF
receptor in signalling by G-protein-coupled receptors, Nature 379 (1996)
557–560.[25] R. Wetzker, F.-D. Bohmer, Transactivation joins multiple tracks to the
ERK/MAPK cascade, Nat. Rev., Mol. Cell Biol. 4 (2003) 651–657.
[26] D.K. Luttrell, L.M. Luttrell, Not so strange bedfellows: G-protein-coupled
receptors and Src family kinases, Oncogene 23 (2004) 7969–7978.
[27] L.J. Pike, L.A. Casey, Cholesterol modulates EGF receptor-mediated
signaling by altering receptor function and trafficking, Biochemistry 41
(2002) 10315–10322.
[28] Y. Fang, A.M. Ferrie, G. Li, Probing cytoskeleton modulation with optical
biosensors, FEBS Lett. 579 (2005) 4175–4180.
[29] Y. Fang, A.M. Ferrie, N.H. Fontaine, P.K. Yuen, Characteristics of dynamic
mass redistribution of EGF receptor signaling in living cells measured with
label free optical biosensor, Anal. Chem. 77 (2005) 5720–5725.
[30] Y. Fang, G. Li, J. Peng, Optical biosensor provides insights for bradykinin
B2 receptor signaling in A431 cells, FEBS Lett. 579 (2005) 6365–6374.
[31] M.A. Cooper, Optical biosensors in drug discovery, Nat. Rev., Drug
Discov. 1 (2002) 515–528.
[32] K. Tiefenthaler, W. Lukosz, Sensitivity of grating couplers as integrated-
optical chemical sensors, J. Opt. Soc. Am. B 6 (1989) 209–220.
[33] D.W. Barnes, Epidermal growth factor inhibits growth of A431 human
epidermoid carcinoma in serum-free cell culture, J. Cell Biol. 93 (1982)
1–4.
[34] M.A. Olayioye, R.M. Neve, H.A. Lane, N.E. Hynes, The ErB Signaling
network: receptor heterodimerization in development and cancer, EMBO
J. 19 (2000) 3159–3167.
[35] S. Grimmer, B. van Deurs, K. Sandvig, Membrane ruffling and
macropinocytosis in A431 cells require cholesterol, J. Cell Sci. 115
(2002) 2953–2962.
[36] N. Dumaz, Y. Light, R. Marais, Cyclic AMP blocks cell growth through
Raf-1-dependent and Raf-1-independent mechanisms, Mol. Cell. Biol. 22
(2002) 3717–3728.
[37] S. Hafner, H.S. Adler, H. Mischak, Mechanism of inhibition of Raf-1 by
protein kinase A, Mol. Cell. Biol. 14 (1994) 6696–6703.
[38] M.C. Maa, T.H. Leu, D.J. McCarley, R.C. Schatzman, S.J. Parsons,
Potentiation of epidermal growth factor receptor-mediated oncogenesis by
c-Src: implications for the etiology of multiple human cancers, Proc. Natl.
Acad. Sci. U. S. A. 92 (1995) 6981–6985.
[39] A. Subtil, I. Gaidarov, K. Kobylarz, M.A. Lampson, J.H. Keem, T.E.
McGraw, Acute cholesterol depletion inhibits clathrin-coated pit budding,
Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 6775–6780.
[40] A. Glading, P. Chang, D.A. Lauffenburger, A. Wells, Epidermal growth
factor receptor activation of calpain is required for fibroblast motility and
occurs via an ERK/MAP kinase signaling pathway, J. Biol. Chem. 275
(2000) 2390–2398.
[41] Z. Lu, G. Jiang, P. Blume-Jensen, T. Hunter, Epidermal growth factor-
induced tumor cell invasion and metastasis initiated by dephosphorylation
and downregulation of focal adhesion kinase, Mol. Cell. Biol. 21 (2001)
4016–4031.
[42] G.S. Kapoor, C. Golden, B. Atkins, K.D. Mehta, pp90RSK- and protein
kinase C-dependent pathway regulates p42/44MAPK-induced LDL
receptor transcription in HepG2 cells, J. Lipid Res. 44 (2003) 584–593.
